Depreciation of Orchestra BioMed Holdings, Inc. from 31 Mar 2022 to 31 Dec 2025

Taxonomy & unit
us-gaap: USD
Description
The amount of expense recognized in the current period that reflects the allocation of the cost of tangible assets over the assets' useful lives. Includes production and non-production related depreciation.
Summary
Orchestra BioMed Holdings, Inc. quarterly and annual Depreciation in USD history and change rate from 31 Mar 2022 to 31 Dec 2025.
  • Orchestra BioMed Holdings, Inc. Depreciation for the quarter ending 31 Dec 2025 was $82,000, a 2.4% decline year-over-year.
  • Orchestra BioMed Holdings, Inc. Depreciation for the twelve months ending 31 Dec 2025 was $327,000, a 6.2% increase year-over-year.
  • Orchestra BioMed Holdings, Inc. annual Depreciation for 2025 was $327,000, a 6.2% increase from 2024.
  • Orchestra BioMed Holdings, Inc. annual Depreciation for 2024 was $308,000, a 7.3% increase from 2023.
  • Orchestra BioMed Holdings, Inc. annual Depreciation for 2023 was $287,000, a 29% increase from 2022.
Source SEC data
View on sec.gov
Depreciation, Trailing 12 Months (USD)
Depreciation, Quarterly (USD)
Depreciation, YoY Quarterly Change (%)
Depreciation, Annual (USD)
Depreciation, YoY Annual Change (%)

Orchestra BioMed Holdings, Inc. Quarterly Depreciation (USD)

Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed Fiscal Year Fiscal Period
Q4 2025 $327,000 $82,000 -$2,000 -2.4% 01 Oct 2025 31 Dec 2025 10-K 12 Mar 2026 2025 FY
Q3 2025 $329,000 $81,000 +$5,000 +6.6% 01 Jul 2025 30 Sep 2025 10-Q 10 Nov 2025 2025 Q3
Q2 2025 $324,000 $81,000 +$7,000 +9.5% 01 Apr 2025 30 Jun 2025 10-Q 12 Aug 2025 2025 Q2
Q1 2025 $317,000 $83,000 +$9,000 +12% 01 Jan 2025 31 Mar 2025 10-Q 12 May 2025 2025 Q1
Q4 2024 $308,000 $84,000 +$11,000 +15% 01 Oct 2024 31 Dec 2024 10-K 12 Mar 2026 2025 FY
Q3 2024 $297,000 $76,000 +$5,000 +7% 01 Jul 2024 30 Sep 2024 10-Q 10 Nov 2025 2025 Q3
Q2 2024 $292,000 $74,000 +$2,000 +2.8% 01 Apr 2024 30 Jun 2024 10-Q 12 Aug 2025 2025 Q2
Q1 2024 $290,000 $74,000 +$3,000 +4.2% 01 Jan 2024 31 Mar 2024 10-Q 12 May 2025 2025 Q1
Q4 2023 $287,000 $73,000 +$2,000 +2.8% 01 Oct 2023 31 Dec 2023 10-K 31 Mar 2025 2024 FY
Q3 2023 $285,000 $71,000 +$17,000 +31% 01 Jul 2023 30 Sep 2023 10-Q 12 Nov 2024 2024 Q3
Q2 2023 $268,000 $72,000 +$23,000 +47% 01 Apr 2023 30 Jun 2023 10-Q 12 Aug 2024 2024 Q2
Q1 2023 $245,000 $71,000 +$23,000 +48% 01 Jan 2023 31 Mar 2023 10-Q 13 May 2024 2024 Q1
Q4 2022 $222,000 $71,000 01 Oct 2022 31 Dec 2022 10-K 27 Mar 2024 2023 FY
Q3 2022 $54,000 01 Jul 2022 30 Sep 2022 10-Q 13 Nov 2023 2023 Q3
Q2 2022 $49,000 01 Apr 2022 30 Jun 2022 10-Q 10 Aug 2023 2023 Q2
Q1 2022 $48,000 01 Jan 2022 31 Mar 2022 10-Q 12 May 2023 2023 Q1

Orchestra BioMed Holdings, Inc. Annual Depreciation (USD)

Period Value YoY Chg Change % Start Date End Date Report Filed Fiscal Year Fiscal Period
2025 $327,000 +$19,000 +6.2% 01 Jan 2025 31 Dec 2025 10-K 12 Mar 2026 2025 FY
2024 $308,000 +$21,000 +7.3% 01 Jan 2024 31 Dec 2024 10-K 12 Mar 2026 2025 FY
2023 $287,000 +$65,000 +29% 01 Jan 2023 31 Dec 2023 10-K 31 Mar 2025 2024 FY
2022 $222,000 01 Jan 2022 31 Dec 2022 10-K 27 Mar 2024 2023 FY
* An asterisk sign (*) next to the value indicates that the value is likely invalid.